Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Lemercinier

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Carbohydrate Research|December 24, 1996
Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine productionX Lemercinier, C Jones
Biologicals : Journal of the International Association of Biological Standardization|August 31, 2000
An NMR spectroscopic identity test for the control of the capsular polysaccharide from Haemophilus influenzae type bX Lemercinier, C Jones
Carbohydrate Research|May 5, 2000
Full assignment of the proton and carbon NMR spectra and revised structure for the capsular polysaccharide from Streptococcus pneumoniae type 17FC Jones, C Whitley, X Lemercinier
Carbohydrate Research|July 11, 1997
Direct preparation of cyclodextrin monophosphatesE Tarelli, X Lemercinier, S Wheeler
Developments in Biologicals|February 24, 2001
Monitoring stability of meningococcal group C conjugate vaccines; correlation of physico-chemical methods and immunogenicity assaysM M Ho, X Lemercinier, B Bolgiano, et al.
Developments in Biological Standardization|January 1, 1996
Physicochemical studies of the structure and stability of polysaccharide-protein conjugate vaccinesC Jones, D T Crane, X Lemercinier, et al.
Developments in Biological Standardization|November 24, 1999
New methods for the characterisation of biopharmaceuticals: conjugate vaccines against Haemophilus influenzae type bX Lemercinier, D Crane, C Gee, et al.
Biotechnology and Applied Biochemistry|March 30, 2001
Solution stability studies of the subunit components of meningococcal C oligosaccharide-CRM197 conjugate vaccinesM M Ho, X Lemercinier, B Bolgiano, et al.
Vaccine|April 20, 2001
Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM(197) conjugate vaccinesB Bolgiano, F Mawas, S E Yost, et al.
Biochemistry|October 5, 2001
High-resolution solution structure of human intestinal trefoil factor and functional insights from detailed structural comparisons with the other members of the trefoil family of mammalian cell motility factorsX Lemercinier, F W Muskett, B Cheeseman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Carbohydrate Research|December 24, 1996
Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine productionX Lemercinier, C Jones
Biologicals : Journal of the International Association of Biological Standardization|August 31, 2000
An NMR spectroscopic identity test for the control of the capsular polysaccharide from Haemophilus influenzae type bX Lemercinier, C Jones
Carbohydrate Research|May 5, 2000
Full assignment of the proton and carbon NMR spectra and revised structure for the capsular polysaccharide from Streptococcus pneumoniae type 17FC Jones, C Whitley, X Lemercinier
Carbohydrate Research|July 11, 1997
Direct preparation of cyclodextrin monophosphatesE Tarelli, X Lemercinier, S Wheeler
Developments in Biologicals|February 24, 2001
Monitoring stability of meningococcal group C conjugate vaccines; correlation of physico-chemical methods and immunogenicity assaysM M Ho, X Lemercinier, B Bolgiano, et al.
Developments in Biological Standardization|January 1, 1996
Physicochemical studies of the structure and stability of polysaccharide-protein conjugate vaccinesC Jones, D T Crane, X Lemercinier, et al.
Developments in Biological Standardization|November 24, 1999
New methods for the characterisation of biopharmaceuticals: conjugate vaccines against Haemophilus influenzae type bX Lemercinier, D Crane, C Gee, et al.
Biotechnology and Applied Biochemistry|March 30, 2001
Solution stability studies of the subunit components of meningococcal C oligosaccharide-CRM197 conjugate vaccinesM M Ho, X Lemercinier, B Bolgiano, et al.
Vaccine|April 20, 2001
Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM(197) conjugate vaccinesB Bolgiano, F Mawas, S E Yost, et al.
Biochemistry|October 5, 2001
High-resolution solution structure of human intestinal trefoil factor and functional insights from detailed structural comparisons with the other members of the trefoil family of mammalian cell motility factorsX Lemercinier, F W Muskett, B Cheeseman, et al.
Pageof 2